| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_39a9f66181ba753d515b2c2ef8e707da |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-551 |
| filingDate |
2005-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f66f31c554b1ca3cbe2de5fc8a34eb17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_74127daaf8f927b8045a45d84f641148 |
| publicationDate |
2006-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2006327942-A |
| titleOfInvention |
Axon regenerative agent |
| abstract |
【Task】 To provide an axonal regeneration agent capable of regenerating central nerves such as spinal cord even in the presence of a substance that inhibits axonal regeneration. [Solution] An axonal regenerative agent containing a Rho kinase inhibitor as a main component is used. [Selection] Figure 1 |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113440649-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2177218-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011149012-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9943525-B2 |
| priorityDate |
2005-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |